title: Dosage of isoniazid and rifampicin poorly predicts drug exposure in tuberculosis patients.
authors: University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
authors: Marieke G G
authors: MG
authors: Sturkenboom
authors: University of Groningen, University Medical Center Groningen, Tuberculosis Centre Beatrixoord, Haren, The Netherlands University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands.
authors: Onno W
authors: OW
authors: Akkerman
authors: University of Groningen, University Medical Center Groningen, Tuberculosis Centre Beatrixoord, Haren, The Netherlands.
authors: Richard
authors: R
authors: van Altena
authors: University of Groningen, University Medical Center Groningen, Tuberculosis Centre Beatrixoord, Haren, The Netherlands University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands.
authors: Wiel C M
authors: WC
authors: de Lange
authors: University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands University of Groningen, Dept of Pharmacy, Pharmacotherapy and Pharmaceutical Care Section, Groningen, The Netherlands.
authors: Jos G W
authors: JG
authors: Kosterink
authors: University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands University of Groningen, University Medical Center Groningen, Dept of Internal Medicine, Groningen, The Netherlands.
authors: Tjip S
authors: TS
authors: van der Werf
authors: University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands j.w.c.alffenaar@umcg.nl.
authors: Jan-Willem C
authors: JC
authors: Alffenaar
mesh_terms: D000995:Antitubercular Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D019540:Area Under Curve; D001835:Body Weight; D004305:Dose-Response Relationship, Drug; D016903:Drug Monitoring; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage* / Q000493:pharmacokinetics; D012293:Rifampin / Q000008:administration & dosage* / Q000493:pharmacokinetics; D014376:Tuberculosis / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents; D007538:Isoniazid; D012293:Rifampin